Dataffinity Health Celebrates Growth with Full Rebrand to New Name Lumiio

Dataffinity Health has announced an official rebrand to celebrate its continued growth and expansion of its programs to 18 countries. The new name Lumiio reflects the guiding force the company has become to other stakeholders across the health communities they work with. KASTx Ventures has been an integral partner supporting Lumiio’s growth through expertise in corporate strategy, governance, business development, and contribution of several key team members through the KASTx Ventures fractional team model. Lumiio is an example of the success of the KASTx Ventures approach in partnering with Read more…

Meet Our Director, Capital Partnerships: Mike Smith 

KASTx Ventures is excited to announce Mike Smith is the latest addition to their team of experts as Director, Capital Partnerships. Smith has had a love for finance for most of his life, taking an interest in stocks at a young age, eventually leading him to pursue a degree in commerce at the University of Toronto. But after an unexpected house visit at the age of 17, his early career took a different turn.   

Meet Our Director, Human Resources: Jan Nighswander

KASTx Ventures is excited to announce the addition of Jan Nighswander to our growing team of experts as our Director of Human Resources. The start to Nighswander’s career was something of a happy accident, she explained. Originally in production accounting in the energy industry, her passion was sparked when she had the opportunity to audit the employee benefits and pension plans of the company she was working for. She fell in love with the work, made the transition into the human resources department, and never looked back.

Meet Our Director of Clinical Development: Janet Petrillo

KASTx Ventures is pleased to announce the addition of Janet Petrillo to our team as Director of Clinical Development. Petrillo brings over 16 years of leading site clinical trials, and has established herself both nationally and internationally as an instrumental leader in the clinical research community. Her years of expertise in all levels of leadership will be incredibly valuable to our scientific partners in advising the development of trials from the ground-up.